KEGG   DRUG: Indenebart
Entry
D12965                      Drug                                   
Name
Indenebart (USAN/INN)
Formula
C6482H10008N1728O2018S46
Exact mass
145816.0778
Mol weight
145906.26
Sequence
(Heavy chain)
EVQLLESGGG LVQPGGSLRL SCAASGFTFS SYAMSWVRQA PGKGLEWVSS ISHLGGSTYY
ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCAGGA NHGKYYYGMD KWGQGTTVTV
SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPEFE
GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPASIEKT ISKAKGQPRE PQVYTLPPSR
EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
(Light chain)
QAVLTQPASL SASPGASASL TCTLRSGAPL PKYRIYWYQQ KPGSPPQYLL RYKSDADKHQ
GSGVPSRFSG SKDASANAGI LLISGLQSED EADYYCMVWD HGVWYFGGGT KLTVLGQPKA
APSVTLFPPS SEELQANKAT LVCLISDFYP GAVTVAWKAD SSPVKAGVET TTPSKQSNNK
YAASSYLSLT PEQWKSHRSY SCQVTHEGST VEKTVAPTEC S
(Disulfide bridge: H22-H96, H149-H205, H225-L220, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'96, H'149-H'205, H'225-L'220, H'266-H'326, H'372-H'430, L22-L96, L143-L202, L'22-L'96, L'143-L'202)
  Type
Peptide
Efficacy
Neurodegenerative diseases agent, Anti-synuclein alpha antibody
  Type
Monoclonal antibody
Comment
Treatment of Parkinson's disease and multiple system atrophy
Target
SNCA [HSA:6622] [KO:K04528]
  Pathway
hsa05012  Parkinson disease
hsa05022  Pathways of neurodegeneration - multiple diseases
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Membrane trafficking
    SNCA
     D12965  Indenebart (USAN/INN)
Other DBs
CAS: 2864437-88-5
PubChem: 503268985
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system